Warm Autoimmune Hemolytic Anemia (WAIHA) Market

Sep 09, 2020

10 likes | 76 Views

Warm Autoimmune Hemolytic Anemia (WAIHA) Market The total prevalent population of Warm Autoimmune Hemolytic Anemia in 7MM was 82,045 in 2017. Among the seven major markets it is observed that the females are more affected with WAIHA as compared to males. In 2017 the market size of Warm Autoimmune Hemolytic Anemia (WAIHA) in 7MM was USD 368 million, which is expected to increase during the forecast period (2017-2030). Increased market opportunity, increasing awareness and increase in the number of research initiatives are some of the key factors expected to drive the Warm Autoimmune Hemolytic Anemia (WAIHA) market forward in the coming years. Some of the key players involved in developing therapies for WAIHA include Rigel Pharmaceuticals, Apellis Pharmaceuticals, Momenta Pharmaceuticals, Immunovant, Alexion Pharmaceuticals, Sanofi and many others. For more details on Warm Autoimmune Hemolytic Anemia (WAIHA) market includes: https://www.delveinsight.com/report-store/warm-autoimmune-hemolytic-anemia-waiha-market

DelveInsight

Download Presentation

Warm Autoimmune Hemolytic Anemia (WAIHA) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D